Home Nitros 8-Hydroxy-5-nitroquinoline

8-Hydroxy-5-nitroquinoline

CAS No.:
4008-48-4
Catalog Number:
AG00BXEW
Molecular Formula:
C9H6N2O3
Molecular Weight:
190.1555
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
97%
In Stock USA
United States
$25
- +
5g
97%
In Stock USA
United States
$75
- +
25g
97%
In Stock USA
United States
$225
- +
Product Description
Catalog Number:
AG00BXEW
Chemical Name:
8-Hydroxy-5-nitroquinoline
CAS Number:
4008-48-4
Molecular Formula:
C9H6N2O3
Molecular Weight:
190.1555
MDL Number:
MFCD00006791
IUPAC Name:
5-nitroquinolin-8-ol
InChI:
InChI=1S/C9H6N2O3/c12-8-4-3-7(11(13)14)6-2-1-5-10-9(6)8/h1-5,12H
InChI Key:
RJIWZDNTCBHXAL-UHFFFAOYSA-N
SMILES:
[O-][N+](=O)c1ccc(c2c1nccc2)O
EC Number:
223-662-4
UNII:
A8M33244M6
Properties
Complexity:
229  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
190.038g/mol
Formal Charge:
0
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
190.158g/mol
Monoisotopic Mass:
190.038g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
78.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.1  
Literature
Title Journal
Experimental and theoretical quantum chemical investigations of 8-hydroxy-5-nitroquinoline. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20121001
Synthesis and characterization of 8-hydroxyquinoline complexes of tin(IV) and their application in organic light emitting diode. Journal of fluorescence 20120901
Substituted oxines inhibit endothelial cell proliferation and angiogenesis. Organic & biomolecular chemistry 20120421
Cox-2 gene overexpression in ureteral stump urothelial carcinoma following nephrectomy for renal cell carcinoma: a case report. Journal of medical case reports 20120101
Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline). Cancer letters 20111215
Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds. ChemMedChem 20110801
Electrochemistry of the antibacterial and antifungal drug nitroxoline and its determination in bulk form, pharmaceutical formulation and human blood. Bioelectrochemistry (Amsterdam, Netherlands) 20110201
Synergistic inhibition of endothelial cell proliferation, tube formation, and sprouting by cyclosporin A and itraconazole. PloS one 20110101
Redox-based inactivation of cysteine cathepsins by compounds containing the 4-aminophenol moiety. PloS one 20110101
Effect of nitroxoline on angiogenesis and growth of human bladder cancer. Journal of the National Cancer Institute 20101215
Thermodynamic investigations of nitroxoline sublimation by simultaneous DSC-FTIR method and isothermal TG analysis. Journal of pharmaceutical sciences 20100101
Evaluation of a Rapid Differentiation Test for Mycobacterium Tuberculosis from other Mycobacteria by Selective Inhibition with p-nitrobenzoic Acid using MGIT 960. Journal of laboratory physicians 20100101
[Species composition and antibiotic resistance of lactobacillus in infants]. Zhurnal mikrobiologii, epidemiologii, i immunobiologii 20100101
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Powder diffraction study of the hydrogen bonds in nitroxoline and its hydrochloride. Acta crystallographica. Section C, Crystal structure communications 20020101
[Is nitroxoline an allergen?]. Therapie 20020101
In vitro activity of the chelating agents nitroxoline and oxine against Mycobacterium bovis BCG. International journal of antimicrobial agents 20011201
Properties